Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mood alterations during deanol therapy.

D E Casey

    Psychopharmacology
    |April 11, 1979
    PubMed
    Summary
    This summary is machine-generated.

    High doses of deanol, an acetylcholine precursor, altered mood in patients, with some developing depression or hypomania. A history of affective symptoms may predispose individuals to these mood changes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Response and remission rates with adjunctive aripiprazole in patients with major depressive disorder who exhibit minimal or no improvement on antidepressant monotherapy.

    International journal of clinical practice·2014
    Same author

    Antipsychotic drugs dose-dependently suppress the spontaneous hyperactivity of the chakragati mouse.

    Neuroscience·2010
    Same author

    Antipsychotic drug-induced weight gain: development of an animal model.

    International journal of obesity (2005)·2005
    Same author

    The behavioral effects of acute and chronic JL 13, a putative antipsychotic, in Cebus non-human primates.

    Psychopharmacology·2001
    Same author

    Effects of benztropine on ketamine-induced behaviors in Cebus monkeys.

    Behavioural pharmacology·2001
    Same author

    Clinical trial design issues in schizophrenic research.

    The Journal of clinical psychiatry·2001
    Same journal

    Effects of repeated treatment with opioids that vary in mu opioid receptor efficacy on pain-depressed locomotor behavior in mice.

    Psychopharmacology·2026
    Same journal

    Cannabidiol in the anterior insular cortex attenuates chronic neuropathic pain and comorbid anxiety- and depression-like behaviors: involvement of CB<sub>1</sub> and 5-HT<sub>1A</sub> receptor signaling.

    Psychopharmacology·2026
    Same journal

    Fentanyl decreases arterial blood oxygen saturation more than furanylfentanyl in mice due to increased apnea.

    Psychopharmacology·2026
    Same journal

    Suicide attempt risk among patients receiving methylphenidate: a retrospective cohort study.

    Psychopharmacology·2026
    Same journal

    Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review.

    Psychopharmacology·2026
    Same journal

    OPRD1 rs4654327 and Outcomes of Extended-Release Naltrexone in Alcohol Use Disorder: An Exploratory Prospective Pharmacogenetic Study.

    Psychopharmacology·2026
    See all related articles

    Area of Science:

    • Neuroscience
    • Psychiatry
    • Pharmacology

    Background:

    • Imbalances in central cholinergic and adrenergic systems are implicated in mood disorders.
    • Deanol is a substance investigated for its potential as an acetylcholine precursor.

    Purpose of the Study:

    • To investigate the effects of high-dose deanol on mood in patients.
    • To explore the relationship between deanol administration, mood alterations, and pre-existing affective symptoms.

    Main Methods:

    • Observational study involving 38 patients treated with high doses of deanol.
    • Monitoring for mood changes and dyskinesias.
    • Reviewing patient histories for affective symptoms.

    Main Results:

    Related Experiment Videos

  • Eight out of 38 patients experienced mood changes, including five cases of depression and three of hypomania.
  • Seven of the eight patients with mood changes had a history of affective symptoms.
  • No correlation was found between deanol-induced dyskinesias and mood alterations.

    • Conclusions:

    • High-dose deanol can induce mood disturbances, such as depression and hypomania, in susceptible individuals.
    • A history of affective symptoms appears to be a potential risk factor for deanol-induced mood changes.
    • Findings suggest implications for managing patients and for future research on the neuropharmacology of mood disorders and deanol.